2. Diabetes C, BloodVitals SPO2 Complications Trial Research G, Nathan DM, et al. The impact of intensive treatment of diabetes on the event and progression of lengthy-time period complications in insulin-dependent diabetes mellitus. N Engl J Med. 3. Effect of intensive blood-glucose management with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. 4. Intensive blood-glucose management with sulphonylureas or insulin in contrast with standard treatment and danger of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. 5. Stratton IM, Adler AI, Neil AW, Matthews DR, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): potential observational study. 6. Parkin CG, Buskirk A, Hinnen DA, Axel-Schweitzer M. Results that matter: structured vs. 2 diabetes. Diabetes Res Clin Pract. 7. Schnell O, Alawi H, Battelino T, et al. Self-monitoring of blood glucose in kind 2 diabetes: current studies.
J Diabetes Sci Technol. 8. Cavalot F, Pagliarino A, Valle M, et al. Postprandial blood glucose predicts cardiovascular events and all-cause mortality in sort 2 diabetes in a 14-12 months comply with-up: lessons from the San Luigi Gonzaga Diabetes Study. 9. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered method: BloodVitals experience position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). 11. Boutati EI, Raptis SA. Self-monitoring of blood glucose as a part of the integral care of sort 2 diabetes. 12. Klonoff DC, BloodVitals experience Blonde L, Cembrowski G, et al. Consensus report: the present function of self-monitoring of blood glucose in non-insulin-treated sort 2 diabetes. J Diabetes Sci Technol. 13. Ceriello A, Barkai L, Christiansen JS, et al. Diabetes as a case study of chronic illness administration with a personalized method: The function of a structured feedback loop.
Diabetes Research and Clinical Practice. 14. Malanda UL, Welschen LMC, Riphagen II, Dekker JM, Nijpels G, Bot SDM. Self-monitoring of blood glucose in patients with kind 2 diabetes mellitus who should not using insulin. Cochrane Database of Systematic Reviews. 15. Polonsky WH, Fisher L, Schikman CH, et al. Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes: Results from the Structured Testing Program examine. 16. Young LA, Buse JB, Weaver MA, et al. Glucose self-monitoring in non-insulin-treated patients with sort 2 diabetes in primary care settings: A randomized trial. 17. Kempf K, Kruse J, Martin S. ROSSO-in-praxi: a self-monitoring of blood glucose-structured 12-week lifestyle intervention significantly improves glucometabolic management of patients with kind 2 diabetes mellitus. 18. Hortensius J, Kars MC, Wierenga WS, Kleefstra N, Bilo HJ, van der Bijl JJ. Perspectives of patients with type 1 or insulin-treated kind 2 diabetes on self-monitoring of blood glucose: a qualitative study.
19. Childs BP, Grothe JM, Greenleaf PJ. Strategies to Limit the Effect of Hypoglycemia on Diabetes Control: Identifying and Reducing the Risks. 20. McQueen R, Ellis S, Maahs D, Anderson H, Nair K, Campbell J. Frequency of Continuous Glucose Monitoring Use and change in Hemoglobin A1C for Adults with Type 1 Diabetes in a Clinical Practice Setting. 21. Gonder-Frederick L, Nyer M, Shepard JA, Vajda K, Clarke W. Assessing concern of hypoglycemia in kids with Type 1 diabetes and their parents. 22. Copeland KC, Silverstein J, Moore KR, et al. Management of newly diagnosed kind 2 Diabetes Mellitus (T2DM) in kids and adolescents. 23. Standards of Medical Care in Diabetes--2018. Diabetes Care. Jan